Different Routes of Proton Pumps Inhibitors Co-Administration have Significant Impact on Mycophenolate Acid (MPA) Serum Levels in Heart Transplant Recipients (original ) (raw )Proton Pump Inhibitor Co-medication Reduces Mycophenolate Acid Drug Exposure in Heart Transplant Recipients
Marcus-André Deutsch
2009
View PDFchevron_right
Proton Pump Inhibitor Co-medication Reduces Active Drug Exposure in Heart Transplant Recipients Receiving Mycophenolate Mofetil
Arnt Kristen
Transplantation Proceedings, 2010
View PDFchevron_right
Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients
M. Hummel , Gino Gerosa
Clinical Transplantation, 2007
View PDFchevron_right
Therapeutic Monitoring of Mycophenolate Mofetil in Organ Transplant Recipients
Pierre Wallemacq
Clinical Pharmacokinetics, 2002
View PDFchevron_right
Correlation of mycophenolic acid pharmacokinetic parameters with side effects in Chinese kidney transplant recipients treated with mycophenolate mofetil
Raf Schepers
Transplantation Proceedings, 2004
View PDFchevron_right
Pharmacokinetics and Pharmacodynamics of Intensified versus Standard Dosing of Mycophenolate Sodium in Renal Transplant Patients
Petra Glander
Clinical Journal of The American Society of Nephrology, 2010
View PDFchevron_right
Pharmacokinetic Basis for the Efficient and Safe Use of Low-Dose Mycophenolate Mofetil in Combination with Tacrolimus in Kidney Transplantation
Pierre Wallemacq
2000
View PDFchevron_right
Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation
Jun-Neng Roan
Annals of Transplantation, 2013
View PDFchevron_right
Lack of Correlation Between MMF Dose and MPA Level in Pediatric and Young Adult Cardiac Transplant Patients: Does the MPA Level Matter?1
Dennis Crowley
American Journal of Transplantation, 2004
View PDFchevron_right
The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy
Domingo Hernández
Nephrology Dialysis Transplantation, 2009
View PDFchevron_right
Concomitant Proton Pump Inhibitors With Mycophenolate Mofetil and the Risk of Rejection in Kidney Transplant Recipients
Jorge Ortiz
Transplantation, 2014
View PDFchevron_right
Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC-MPS) co-administered with cyclosporine in the early-phase post-kidney transplantation
Eberhard Wieland , Catherine M T Sherwin , Alexander Vinks
Clinical Transplantation, 2012
View PDFchevron_right
Pharmacokinetics of Mycophenolic Acid after Mycophenolate Mofetil Administration in Liver Transplant Patients Treated with Tacrolimus
Vijay Warty
The Journal of Clinical Pharmacology, 2001
View PDFchevron_right
Effect of T-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil
Vijay Warty , Shimin Zhang
Liver Transplantation and Surgery, 1999
View PDFchevron_right
Therapeutic Drug Monitoring of Mycophenolic Acid as a Precision Medicine Tool for Heart Transplant Patients: Results of an Observational Pharmacokinetic Pilot Study
massimo baraldo
Pharmaceutics
View PDFchevron_right
Value of therapeutic drug monitoring of MMF therapy in pediatric transplantation
Guido Filler
Pediatric Transplantation, 2006
View PDFchevron_right
The Rationale for and Limitations of Therapeutic Drug Monitoring for Mycophenolate Mofetil in Transplantation
Leslie Shaw
Transplantation, 2005
View PDFchevron_right
Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients
Magdalena Korecka
Clinical Biochemistry, 2001
View PDFchevron_right
Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant
M. Durlik
Journal of Clinical Pharmacy and Therapeutics, 2006
View PDFchevron_right
Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients
Petra Reinke
Transplant International, 2012
View PDFchevron_right
Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene Polymorphism
Filiz Aydin
Transplantation Proceedings, 2017
View PDFchevron_right
Mycophenolate Mofetil Pharmacokinetic Monitoring in Pediatric Kidney Transplant Recipients
Luca Strologo
Transplantation Proceedings, 2005
View PDFchevron_right
Quantification of Mycophenolic Acid in Plasma Samples Collected during and Immediately after Intravenous Administration of Mycophenolate Mofetil
E. Schütz
Clinical Chemistry, 2001
View PDFchevron_right
The need of mycophenolic acid monitoring in long-term renal transplants
Paschoalina Romano
Clinical Transplantation, 2005
View PDFchevron_right
A Double Absorption-Phase Model Adequately Describes Mycophenolic Acid Plasma Profiles in De Novo Renal Transplant Recipients Given Oral Mycophenolate Mofetil
Yvon Lebranchu , Jean Debord
Clinical Pharmacokinetics, 2005
View PDFchevron_right
The CLEAR Study: A 5-day, 3-g Loading Dose of Mycophenolate MofetilversusStandard 2-g Dosing in Renal Transplantation
Ahmed Shoker
Clinical Journal of the American Society of Nephrology, 2010
View PDFchevron_right
Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression
Guido Filler
Pediatric Nephrology, 2000
View PDFchevron_right
Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial
Anders Hartmann
Transplantation, 2008
View PDFchevron_right
Pharmacokinetics of Mycophenolic Acid in Kidney Transplant Patients Receiving Sirolimus Versus Cyclosporine
Antoine Coquerel
Transplantation Proceedings, 2005
View PDFchevron_right
Time-dependent clearance of mycophenolic acid in renal transplant recipients
Teun Van Gelder
British Journal of Clinical Pharmacology, 2007
View PDFchevron_right
INTRAVENOUS MYCOPHENOLATE MOFETIL (MMF): SAFETY, TOLERABILITY, AND PHARMACOKINETICS
Dilip Kittur
Transplantation, 1999
View PDFchevron_right